We are live on ! Find out more
EPZM

Epizyme, Inc
EPZM

Delisted

EPZM was delisted on the 11th of August, 2022.

Back to rankings

95 hedge funds and large institutions have $823M invested in Epizyme, Inc in 2017 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 30 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,030% more call options, than puts

Call options by funds: $1.51M | Put options by funds: $134K

75% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 8

40% more capital invested

Capital invested by funds: $589M → $823M (+$234M)

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

1% more funds holding

Funds holding: 94 → 95 (+1)

0% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 30

Holders
95
Holders Change
+1
Holders Change %
+1.06%
% of All Funds
2.36%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.12%
New
14
Increased
30
Reduced
30
Closed
8
Calls
$1.51M
Puts
$134K
Net Calls
+$1.38M
Net Calls Change
+$1.39M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$42.8M
2
PAI
Palo Alto Investors
California
+$23.4M
3
OIM
Oracle Investment Management
Connecticut
+$6.89M
4
CC
Casdin Capital
New York
+$2.8M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.85M

Top Sellers

Rank Fund Capital Flow
1
MAM
MPM Asset Management
Massachusetts
-$20.9M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$15.7M
3
VOYA Investment Management
VOYA Investment Management
Georgia
-$4.97M
4
DM
Deerfield Management
New York
-$2.5M
5
QF
QVT Financial
New York
-$2.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$3.83M +$1.05M +78,801 +54%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$3.38M +$199K +14,978 +8%
CS
28
Candriam SCA
Luxembourg
$3.29M -$226K -17,000 -8%
JP Morgan Chase
29
JP Morgan Chase
New York
$3.22M -$288K -21,650 -10%
Charles Schwab
30
Charles Schwab
California
$2.77M +$435K +32,650 +25%
CAM
31
Cormorant Asset Management
Massachusetts
$2.4M -$260K -19,513 -12%
California Public Employees Retirement System
32
California Public Employees Retirement System
California
$2.27M -$77.3K -5,800 -4%
Renaissance Technologies
33
Renaissance Technologies
New York
$1.98M +$1.53M +115,188 New
TCIM
34
TIAA CREF Investment Management
New York
$1.85M -$87.3K -6,558 -6%
QI
35
QS Investors
New York
$1.62M – – –
Principal Financial Group
36
Principal Financial Group
Iowa
$1.61M +$6.86K +515 +0.5%
Morgan Stanley
37
Morgan Stanley
New York
$1.42M -$591K -44,358 -35%
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$1.36M -$49.3K -3,700 -4%
IHM
39
Iguana Healthcare Management
New York
$1.29M +$999K +75,000 New
TA
40
Teachers Advisors
New York
$1.2M +$27.9K +2,093 +3%
Swiss National Bank
41
Swiss National Bank
Switzerland
$1.14M – – –
Dimensional Fund Advisors
42
Dimensional Fund Advisors
Texas
$1.12M +$330K +24,807 +61%
Deutsche Bank
43
Deutsche Bank
Germany
$914K -$1.31M -98,672 -65%
D.E. Shaw & Co
44
D.E. Shaw & Co
New York
$867K +$674K +50,577 New
AA
45
ALPS Advisors
Colorado
$856K -$77.8K -5,842 -10%
CS
46
Credit Suisse
Switzerland
$848K +$80.8K +6,070 +14%
Goldman Sachs
47
Goldman Sachs
New York
$839K -$59.3K -4,451 -8%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$838K +$19.3K +1,448 +3%
EIM
49
Essex Investment Management
Massachusetts
$812K -$166K -12,433 -21%
Russell Investments Group
50
Russell Investments Group
United Kingdom
$778K +$225K +16,924 +60%
1
2
3 4 5

EPZM Hedge Fund Activity: Q1 2017 in Review

95 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q1 2017, worth a combined $823M — up 40% from $589M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new EPZM positions and 8 closed out — a net gain of 6 holders — while 30 added to existing stakes and 30 trimmed.

The largest buyer was BlackRock, adding an estimated $42.8M. The largest seller was MPM Asset Management, exiting entirely with an estimated $20.9M sold.

  • 95 institutional investors held Epizyme, Inc (EPZM) as of Q1 2017, up from 94 in Q4 2016.
  • Funds reported $823M of Epizyme, Inc stock for Q1 2017, up 40% quarter-over-quarter.
  • 14 funds opened new Epizyme, Inc positions in Q1 2017 and 8 closed out, a net change of +6 holders.
  • The largest Epizyme, Inc buyer in Q1 2017 was BlackRock, an estimated $42.8M added.
  • The largest Epizyme, Inc seller in Q1 2017 was MPM Asset Management, an estimated $20.9M sold.

Based on aggregated 13F filings for Q1 2017.